MedKoo Cat#: 130434 | Name: EVT801
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

EVT801 is a VEGFR-3 inhibitor that displays antitumor activity as well as decreased toxicity as compared to sorafenib and pazopanib.

Chemical Structure

EVT801
EVT801
CAS#1412453-70-3

Theoretical Analysis

MedKoo Cat#: 130434

Name: EVT801

CAS#: 1412453-70-3

Chemical Formula: C19H21N5O3

Exact Mass: 367.1644

Molecular Weight: 367.41

Elemental Analysis: C, 62.11; H, 5.76; N, 19.06; O, 13.06

Price and Availability

Size Price Availability Quantity
5mg USD 1,250.00 2 Weeks
10mg USD 1,950.00 2 Weeks
25mg USD 3,850.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
EVT801; EVT 801; EVT-801
IUPAC/Chemical Name
(R)-2-amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-3-(1H-imidazol-2-yl)-1,8-naphthyridin-4(1H)-one
InChi Key
FQPLKTQWEHDNAB-LJQANCHMSA-N
InChi Code
InChI=1S/C19H21N5O3/c1-4-24-16(20)14(17-21-9-10-22-17)15(25)13-6-5-12(23-18(13)24)7-8-19(2,26)11-27-3/h5-6,9-10,26H,4,11,20H2,1-3H3,(H,21,22)/t19-/m1/s1
SMILES Code
O=C1C(C2=NC=CN2)=C(N)N(CC)C3=NC(C#C[C@@](C)(O)COC)=CC=C13
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 367.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Paillasse MR, Esquerré M, Bertrand FA, Poussereau-Pomié C, Pichery M, Visentin V, Gueguen-Dorbes G, Gaujarengues F, Barron P, Badet G, Briaux A, Ancey PB, Sibrac D, Erdociain E, Özcelik D, Meneyrol J, Martin V, Gomez-Brouchet A, Selves J, Rochaix P, Battistella M, Lebbé C, Delord JP, Dol-Gleizes F, Bono F, Blanc I, Alam A, Hunneyball I, Whittaker M, Fons P. Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy. Cancer Res Commun. 2022 Nov 29;2(11):1504-1519. doi: 10.1158/2767-9764.CRC-22-0151. PMID: 36970050; PMCID: PMC10035370.